THE ALTASCIENTIST

A scientific journal by Altasciences in which we delve deep into the processes, challenges, trends, and innovations in drug development. Available to read or listen to as an audiobook. Subscribe to the audiobook series on Spotify, Apple Podcasts, or wherever you listen to audio content.

ISSUE NO. 35 — Critical Considerations for the Safe and Compliant Manufacture of Highly Potent Drugs

The Altascientist

ISSUE NO. 35 — Critical Considerations for the Safe and Compliant Manufacture of Highly Potent Drugs

Aug 24, 2023

ISSUE NO. 34 — Toxicokinetics, Pharmacokinetics, and Pharmacodynamics

The Altascientist

ISSUE NO. 34 — Toxicokinetics, Pharmacokinetics, and Pharmacodynamics

Aug 22, 2023

ISSUE NO. 33 — End-to-End CNS Drug Development Solutions

The Altascientist

ISSUE NO. 33 — End-to-End CNS Drug Development Solutions

Apr 17, 2023

ISSUE NO. 32 — A Changing Paradigm for Non-Rodent Species in Nonclinical Safety Studies

The Altascientist

ISSUE NO. 32 — A Changing Paradigm for Non-Rodent Species in Nonclinical Safety Studies

Mar 22, 2023

ISSUE NO. 31 — The Advantages of Conducting Early Phase Clinical Research in Canada

The Altascientist

ISSUE NO. 31 — The Advantages of Conducting Early Phase Clinical Research in Canada

Feb 13, 2023

ISSUE NO. 30 — The Evolution and Advancement of Liquid Chromatography-Mass Spectrometry in Drug Development

The Altascientist

ISSUE NO. 30 — The Evolution and Advancement of Liquid Chromatography-Mass Spectrometry in Drug Development

Dec 19, 2022

ISSUE NO. 29 — Building Your Early Phase Clinical Data, from Protocol to Regulatory Submission

The Altascientist

ISSUE NO. 29 — Building Your Early Phase Clinical Data, from Protocol to Regulatory Submission

Dec 2, 2022